We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$249B
AUM Growth
+$21.1B
Cap. Flow
+$954M
Cap. Flow %
0.38%
Top 10 Hldgs %
24.48%
Holding
3,558
New
327
Increased
1,436
Reduced
1,300
Closed
241

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.27B
2
V icon
Visa
V
+$459M
3
NKE icon
Nike
NKE
+$410M
4
ETSY icon
Etsy
ETSY
+$311M
5
GEN icon
Gen Digital
GEN
+$235M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Healthcare 14.38%
3 Consumer Discretionary 13.88%
4 Financials 12.81%
5 Communication Services 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNTH icon
2926
Dianthus Therapeutics
DNTH
$5.84B
$375K ﹤0.01%
2,394
+250
+12% +$45.9K
PLSE icon
2927
Pulse Biosciences
PLSE
$2.43B
$375K ﹤0.01%
22,849
+1,000
+5% +$19K
VERV
2928
DELISTED
Verve Therapeutics
VERV
$375K ﹤0.01%
+6,219
New +$258K
URGN icon
2929
UroGen Pharma
URGN
$1.86B
$374K ﹤0.01%
24,500
+2,600
+12% +$47K
LOCO icon
2930
El Pollo Loco
LOCO
$501M
$373K ﹤0.01%
20,396
-513,144
-96% -$8.78M
ZYXI
2931
DELISTED
Zynex
ZYXI
$372K ﹤0.01%
26,351
+1,980
+8% +$27.4K
NPK icon
2932
National Presto Industries
NPK
$870M
$371K ﹤0.01%
3,652
-3,627
-50% -$374K
UFI icon
2933
UNIFI
UFI
$119M
$371K ﹤0.01%
15,210
XENE icon
2934
Xenon Pharmaceuticals
XENE
$6.06B
$371K ﹤0.01%
+19,908
New +$367K
CURO
2935
DELISTED
CURO Group Holdings Corp.
CURO
$371K ﹤0.01%
21,800
-2,000
-8% -$31.1K
UVSP icon
2936
Univest Financial
UVSP
$1.22B
$370K ﹤0.01%
14,032
-2,500
-15% -$70.2K
CAMP
2937
DELISTED
CalAmp Corp.
CAMP
$370K ﹤0.01%
1,264
-179
-12% -$53.4K
HCCI
2938
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$370K ﹤0.01%
12,450
-600
-5% -$17.8K
SPWR icon
2939
SunPower Inc
SPWR
$60.6M
$369K ﹤0.01%
+38,077
New +$373K
FCBC icon
2940
First Community Bankshares
FCBC
$900M
$368K ﹤0.01%
12,345
-1,200
-9% -$36.3K
HWKN icon
2941
Hawkins
HWKN
$2.67B
$368K ﹤0.01%
11,234
KE
2942
Kimball Electronics
KE
$595M
$368K ﹤0.01%
16,947
DCRNW
2943
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$368K ﹤0.01%
+252,219
New +$307K
CATO icon
2944
Cato Corp
CATO
$68.3M
$366K ﹤0.01%
21,703
-2,600
-11% -$38.5K
INSW icon
2945
International Seaways
INSW
$4.76B
$366K ﹤0.01%
19,065
-2,470
-11% -$48K
DXPE icon
2946
DXP Enterprises
DXPE
$2.43B
$365K ﹤0.01%
10,961
-3,700
-25% -$114K
SEI
2947
Solaris Energy Infrastructure
SEI
$3.15B
$363K ﹤0.01%
37,300
+2,200
+6% +$23.3K
IRMD icon
2948
iRadimed
IRMD
$1.16B
$362K ﹤0.01%
12,300
+200
+2% +$5.51K
PDFS icon
2949
PDF Solutions
PDFS
$1.93B
$362K ﹤0.01%
19,896
-1,000
-5% -$17.9K
HARP
2950
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$362K ﹤0.01%
2,610
+1,080
+71% +$206K

Similar funds

AllianceBernstein's Q2 2021 Portfolio in Review

As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
  • AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
  • AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
  • AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
  • AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
  • AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
  • AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.